Clinical Trial Update: ED90 for Hyperbaric Bupivacaine in Super Obese Parturients [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the ED90 dose of hyperbaric bupivacaine for spinal anesthesia in super-obese parturients undergoing cesarean delivery; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Morbid Obesity

Drugs mentioned

• Hyperbaric Bupivacaine (bupivacaine)

Snippet

Sponsor: Duke University | Conditions: Obesity, Morbid, Spinal Anesthesia | Phase 4 | Status: COMPLETED | Results posted: 2026-04-17